SERPINA1 and alpha 1-antitrypsin deficiency: The number of AAT deficient individuals in the U.S. population is likely to be even more as some patients with AAT deficiency have not developed COPD (e.g. children), COPD has yet to be detected in them, or have undiagnosed AAT deficiency-associated liver disease.